Original research| Volume 7, ISSUE 2, P159-165, July 2013

Download started.


Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: A retrospective study

Published:January 31, 2013DOI:



      To report the characteristics and treatment of individuals requiring emergency ambulance services for severe hypoglycaemia and estimate associated provider costs.


      Retrospective analysis of routinely collected data collected by the East Midlands Ambulance Trust, UK, of episodes of severe hypoglycaemia attended by emergency ambulance services during a four-month period. Standard clinical measures, response time, on-site treatment and transportation were recorded and ambulance services costs calculated.


      90,435 emergency calls were recorded, 523 (0.6%) for severe hypoglycaemia, equating to an incidence of to 2.76 per 100 patient years; 74% of individuals were insulin-treated, 28% of events occurred nocturnally (00:00–07:59), and 32% were transported to hospital. Higher respiratory rate was a positive predictor (p = 0.03), whereas higher post treatment blood glucose (p = 0.05) and insulin treatment (p < 0.01) were negative predictors of transport to hospital. Median treatment costs for individuals transported and not transported to hospital were £92 and £176 respectively.


      Most cases of severe hypoglycaemia requiring assistance from emergency ambulance services are successfully treated at the scene. Individuals not responding to treatment or were non insulin-treated were more likely to be transported to hospital. Further studies are needed to evaluate the effect of prehospital ambulance care by treatment and diabetes type on subsequent outcomes.


      UK (United Kingdom), NICE (National Institute for Clinical Excellence)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • The Diabetes Control and Complications Trial Research Group
        The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependant diabetes mellitus.
        New England Journal of Medicine. 1993; 329: 977-986
        • Bonds B.
        • et al.
        The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
        British Medical Journal. 2010; 340: b4909
        • Gold A.
        • MacLeod K.
        • Frier B.M.
        Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia.
        Diabetes Care. 1994; 17: 697-703
        • Graveling A.
        • Frier B.M.
        Impaired awareness of hypoglycaemia: a review.
        Diabetes & Metabolism. 2010; 36 (pp. S64–S74)
        • Frier B.M.
        Hypoglycaemia in the diabetic adult.
        Baillieres Clinical Endocrinology and Metabolism. 1993; 7: 567-623
        • Noh R.
        • Graveling A.J.
        • Frier B.M.
        Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
        Expert Opinion on Pharmacotherapy. 2011; 12: 2161-2175
        • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
        Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
        New England Journal of Medicine. 2005; 353: 2643-2653
        • Leese G.
        • et al.
        Frequency of severe hypoglycaemia requiring emergency treatment in type 1 and type 2 diabetes.
        Diabetes Care. 2003; 26: 1176-1180
        • Farmer A.J.
        • Brockbank K.J.
        • Keech M.L.
        • England E.J.
        • Deakin C.D.
        Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England.
        Diabetic Medicine. 2012; 29: 1447-1450
        • Graveling A.
        • Frier B.M.
        Hypoglycaemia: an overview.
        Primary Care Diabetes. 2009; : 131-139
      1. Public Health Observatories, (accessed 30.03.12).

      2. National Diabetes and Audit, (accessed 30.03.12).

        • Davis S.
        • et al.
        Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes.
        Diabetes. 2009; 58: 701-709
        • Feldman-Billard S.
        • et al.
        Hypoglycemia-induced blood pressure elevation in patients with diabetes.
        Archives of Internal Medicine. 2010; 170: 829-831
        • Heller S.
        • Cryer P.
        Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans.
        Diabetes & Metabolism. 1991; 40: 223-226
        • Donnelly L.
        • et al.
        Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study.
        Diabetic Medicine. 2005; 22: 749-755
        • Leese P.
        • et al.
        Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes.
        Diabetes Care. 2003; 26: 1176-1180
        • UK Hypoglycaemia Study Group
        Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
        Diabetologia. 2007; 50: 6
        • UK Prospective Diabetes Study (UKPDS) Group
        Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
        Lancet. 1998; 352: 837-853
        • Zoungas S.
        • et al.
        Severe hypoglycemia and risks of vascular events and death.
        New England Journal of Medicine. 2010; 363: 1410-1418
        • The Action to Control Cardiovascular Risk in Diabetes Study Group
        Effects of intensive glucose lowering in type 2 diabetes.
        New England Journal of Medicine. 2008; 358: 24
        • Ray K.
        • et al.
        Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
        The Lancet. 2009; 373: 1765-1772
        • Montori V.
        • Fernández-Balsells M.
        Glycemic control in type 2 diabetes: time for an evidence-based about-face?.
        Annals of Internal Medicine. 2009; 150: 803-808
        • Gruden G.
        • et al.
        QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes. From the EURODIAB IDDM Complications Study.
        Diabetes Care. 2012; 35: 125-127
        • Frier B.M.
        • Schernthaner G.
        • Heller S.R.
        Hypoglycemia and cardiovascular risks.
        Diabetes Care. 2011; 34: S132-S137
        • Laitinen T.
        • et al.
        Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects.
        Annals of Noninvasive Electrocardiology. 2008; 13: 97-105
        • Brackenridge A.
        • et al.
        Emergency management of diabetes and hypoglycaemia.
        Emergency Medical Journal. 2006; 23: 183-185
        • Amiel S.
        • et al.
        Hypoglycaemia in type 2 diabetes.
        Diabetic Medicine. 2008; 25
        • Hammer M.
        • et al.
        Costs of managing severe hypoglycaemia in three European countries.
        Journal of Medical Economics. 2009; 12: 281-290
        • Brod M.
        • Christensen T.
        • Bushnell D.
        Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey.
        Journal of Medical Economics. 2012; 15: 77-86
        • The DCCT Research Group
        Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial.
        American Journal of Medicine. 1991; 90: 450-459
        • Chico A.
        • et al.
        The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control.
        Diabetes Care. 2003; 26: 1153-1157
      3. National Insitute for Health and Clinical Excellence Quality Standards Programme: Diabetes in Adults, 2011.

        • UK Hypoglycaemia Study Group
        Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
        Diabetologia. 2007; 50: 1140-1147
        • Cryer P.
        • Davis S.
        • Shamoon H.
        Hypoglycemia in diabetes.
        Diabetes Care. 2003; 26: 1902-1912